Ventria Bioscience Inc. Scores Key Victory in Fight Against Infringing Chinese Recombinant Albumin

For immediate release – Junction City, KS  Last week, Ventria Bioscience Inc. obtained an important win in its effort to stop the importation and sale of infringing recombinant albumin made in China by Wuhan Healthgen Biotechnology Corp. On August 18, 2021, the U.S. International Trade Commission (ITC) formally found three U.S. distributors of such products—Aspira […]

Ventria Bioscience’s ExpressTec Delivers the Power to Improve the Health Status of Children in Developing Countries

Junction City, Kansas – November 21, 2019 – A recent publication, Human Milk Proteins: Their Power to Improve the Health Status of Children in Developing Countries, explores the critical health benefits of synthetic human breastmilk proteins for children in developing countries. In poverty-stricken areas, children are more likely to suffer from Environmental Enteric Dysfunction (EED) […]

Design and Objectives of the ELCIE Clinical Trial

Effects of rhLactoferrin on Chronic Inflammation in the Elderly: Design and Objectives of the ELCIE Clinical Trial We have previously introduced an ongoing clinical study, headed by principal investigator Jeremy Walston, MD,  Johns Hopkins School of Medicine, aimed at finding out if recombinant human lactoferrin (rhLactoferrin) produced from Ventria Bioscience’s ExpressTec biologic manufacturing system may […]

Breastmilk and the developing infant brain

In a previous post, we discussed how the composition of human breastmilk protects infant health and aids in the early development of the gut and immune system. We also talked about how some of those beneficial properties can be isolated to specific milk proteins that can now be produced affordably, in high yield, for clinical […]

Studying a potential new insulin analog for diabetes therapy

Toward a better insulin analog: improving product yield enables scientific study of potential new diabetes therapy. Daily injections of the pancreatic peptide-hormone insulin are essential to life for many people living with type 1 or advanced type 2 diabetes. While therapeutic insulin was originally available only by purifying it from animal sources, in 1982 a […]

Ventria Bioscience partners with BMGF to address pediatric diarrhea in the developing world

In our last post, we discussed results from a re-analysis of the Global Enteric Multicenter Study (GEMS), which found that the key pathogens responsible for nearly 80% of worldwide cases of pediatric diarrhea are Shigella spp, rotavirus, adenovirus 40/41, heat-stable enterotoxigenic E. coli (ETEC), Cryptosporidium spp, and Campylobacter spp. Previously, we also discussed a study, […]

Causes of diarrhea in children: The Global Enteric Multicenter Study (GEMS)

Worldwide, diarrheal diseases are the second leading cause of death in children younger than 5 years of age, killing approximately half a million children every year. The causes of diarrhea are multifold, and public health efforts to address this challenge require reliable, consistent estimates of pathogen burden. The Global Enteric Multicenter Study (GEMS) was a […]

Protecting American scientific innovation for the greater good

In 2013, US Customs officers discovered something suspicious—packets of rice seeds—in baggage belonging to Chinese travelers heading home after a visit to the U.S. It turns out that the travelers were employees of a Chinese crop-research institute, and had been handed the seeds in an act of attempted industrial espionage. Ventria Bioscience CEO Scott Deeter […]